EU medtech industry fears voice will be weakened post regulatory reforms
This article was originally published in SRA
Executive Summary
Speculation is mounting that the medical device industry in the EU will in future have less influence in decision-making relating to the implementation of regulations and laws affecting the sector than it has at present. Industry body Eucomed argues that "the current level of stakeholder dialogue" should remain.